In patients attending a pigmented lesion clinic, users of tan-enhancing agents (Melanotan I and II) used sunbeds more frequently than nonusers.
In plain wordsIn clinic patients, people who used tan-enhancing agents (Melanotan I and II) were linked to more frequent sunbed use than nonusers.
- Peptide
- Melanotan I (afamelanotide)
- Outcome
- IncreaseSunbed use frequency by tan-enhancing agent use
- Study
n: not reported in source
- Comparator
- Nonusers of tan-enhancing agents
- Outcome group
- Skin and hair · Skin and wound
Source sentences
Users of tan-enhancing agents also used sunbeds more frequently compared with nonusers.
1 context sentence(design, population, supporting numbers)
This was done using a self-reported anonymous survey where respondents answered questions relating to their own demographic data, frequency of sunbed use, motivation for sunbed use and use of unregulated tan-enhancing agents (namely Melanotan I and II).
In this study, Melanotan I (afamelanotide) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Melanotan I (afamelanotide).